leadf
logo-loader
ASX:MDC

Medlab Clinical Ltd

 Receive alerts
Market:
ASX
Market Cap:
$100.68 m
Price
0.36 AUD
Change
28.57%
52 weeks high
0.37
52 weeks low
0.13
05.36

Director Interviews

In brief

Medlab Clinical Ltd (ASX:MDC) is listed on the Australian Securities Exchange.

In brief Deep dive Research Latest news Insight Interviews

Deep dive We explore the investor case for growth companies

Medlab Clinical inks UK and US distribution deals for nutraceuticals
Medlab Clinical Ltd - Medlab Clinical dispenses record numbers of cannabis bottles as it enrols last trial patient

Snapshot

Medlab Clinical Ltd revealed in December that it had raised $5mln in an oversubscribed share placement

Open Deep dive

Latest news

Medlab Clinical completes first order of new hybrid cannabinoid to UK

on 29/6/20

Medlab Clinical raises $5.4 million in well-supported placement

on 15/6/20

Medlab Clinical's NanoCBD available in Australia with first SAS scheme...

on 11/6/20

S&P/ASX 200 extends winning streak despite negative GDP growth in March quarter

on 3/6/20

Medlab Clinical receives first three batches of NanaBis™ from Tasmanian...

on 3/6/20

Pharma companies buck the trend to outshine other sectors in Asia-Pacific region

on 8/5/20

Medlab Clinical achieves record March quarter for NanaBis™ with 26% increase...

on 27/4/20

Medlab Clinical extends Nanocelle™ platform to anti-malaria drug as part of...

on 21/4/20

Watch

Medlab Clinical Ltd - Medlab Clinical's Dr Sean Hall details new FeverMates agreement Director Interviews Medlab Clinical's Dr Sean Hall details new FeverMates agreement
on 6/4/20
1557286341_MDC-thumb.jpg Director Interviews Medlab Clinical forges ahead in new vitamin trials for chronic illnesses
on 8/5/19
1552359852_MDC-MAR.jpg Director Interviews Medlab Clinical chief updates on progress with NanaBis and NRG Biotic
on 12/3/19
1549513375_MDC-FEB.jpg Director Interviews Medlab Clinical accelerating VMS business in Australia, and NanaBis globally
on 7/2/19
View all